Trial Profile
Effect of Guanfacine on Opioid-induced Hyperalgesia (OIH) and Tolerance
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 16 Mar 2023
Price :
$35
*
At a glance
- Drugs Guanfacine (Primary) ; Morphine
- Indications Hyperalgesia; Pain
- Focus Therapeutic Use
- 13 Mar 2023 Planned End Date changed from 1 Dec 2022 to 1 Dec 2023.
- 04 Apr 2022 Planned End Date changed from 1 Dec 2021 to 1 Dec 2022.
- 04 Apr 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Dec 2022.